Gilles Van Cutsem, MD, DTM, MPH - Médecins Sans Frontières - Dr

Gilles Van Cutsem

MD, DTM, MPH

Médecins Sans Frontières

Dr

Cape Town | South Africa

Main Specialties: Epidemiology, Infectious Disease, Public Health

ORCID logohttps://orcid.org/0000-0002-8972-4480


Top Author

Gilles Van Cutsem, MD, DTM, MPH - Médecins Sans Frontières - Dr

Gilles Van Cutsem

MD, DTM, MPH

Introduction

Gilles Van Cutsem is a humanitarian doctor, epidemiologist and researcher who currently serves as a senior HIV & TB Adviser for Médecins Sans Frontières’s Southern African Medical Unit and as an Honorary Research Associate at the Centre for Infectious Disease Epidemiology and Research of the University of Cape Town. In 2019 he became the leader of MSF’s international HIV/AIDS Working Group.
His work with Doctors without Borders (MSF) in sub-Saharan Africa spans over two decades, most of it caring for people with HIV and TB in South Africa, but also coordinating various other emergency responses such as the Ebola epidemic in West Africa and the recent cyclone in Mozambique.
He holds a Medical Doctor degree from the University of Louvain, a Diploma of Tropical Medicine from the Institute for Tropical Medicine in Antwerp and a Masters in Public Health and Epidemiology from the University of Cape Town.

Primary Affiliation: Médecins Sans Frontières - Cape Town , South Africa

Specialties:

Research Interests:


View Gilles Van Cutsem’s Resume / CV

Education

Jun 2008
University of Cape Town, Cape Town, South Africa
Master in Public Health
MPH
Mar 1998
Institute for Tropical Medicine, Antwerpen, Belgium
Diploma in Tropical Medicine
DTM
Sep 1997
Catholic University of Louvain, Brussels, Belgium
Medical Doctor
MD
Jun 1993
Faculté Notre Dame de La Paix, Namur, Belgiu,
Bachelor of Science
B Sc

Experience

Jun 2019
Leader MSF HIV/AIDS Working Group
Leader
Apr 2016
Senior HIV/TB Adviser
Adviser
Jun 2010
Medical Coordinator
Country Medical Coordinator
South Africa
Jan 2007
Project Coordinator
Coordinator of MSF's HIV/TB project in Khayelitsha, South /Africa
Jun 2003
Clinician
Clinical care and coordination of research activities
Khayelitsha HIV/TB project

Publications

69Publications

1155Reads

190Profile Views

Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme.

Int J Infect Dis 2020 Jun 29;95:459-461. Epub 2020 Feb 29.

Doctors Without Borders South Africa, Johannesburg, South Africa; Centre for Infectious Disease and Research, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2020.02.057DOI Listing
June 2020
2.330 Impact Factor

Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV.

PLoS One 2018 19;13(1):e0191294. Epub 2018 Jan 19.

Médecins sans Frontières, Southern Africa Medical Unit, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191294PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774776PMC
February 2018
4 Reads
3.234 Impact Factor

Who Needs to Be Targeted for HIV Testing and Treatment in KwaZulu-Natal? Results From a Population-Based Survey.

J Acquir Immune Defic Syndr 2016 Dec;73(4):411-418

*Epicentre, Paris, France; †Médecins Sans Frontières, Cape Town, South Africa; ‡Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa; §Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa; and ‖Institut de Recherche pour le Développement, UMI 233-INSERM U1175-Montpellier University, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172512PMC
December 2016
8 Reads
4.556 Impact Factor

Adherence clubs for long-term provision of antiretroviral therapy: cost-effectiveness and access analysis from Khayelitsha, South Africa.

Trop Med Int Health 2016 09 10;21(9):1115-23. Epub 2016 Jul 10.

Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tmi.12736DOI Listing
September 2016
4 Reads
2.329 Impact Factor

The uncertain future of lay counsellors: continuation of HIV services in Lesotho under pressure.

Health Policy Plan 2016 Jun 5;31(5):592-9. Epub 2015 Nov 5.

Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/heapol/czv106DOI Listing
June 2016
36 Reads
3.470 Impact Factor

Supervised oral HIV self-testing is accurate in rural KwaZulu-Natal, South Africa.

Trop Med Int Health 2016 06 11;21(6):759-67. Epub 2016 May 11.

Médecins Sans Frontières, South Africa Mission, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tmi.12703DOI Listing
June 2016
11 Reads
2.329 Impact Factor

Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.

Clin Infect Dis 2016 05;62 Suppl 3:S238-43

Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa Division of Medical Microbiology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845888PMC
May 2016
23 Reads
8.886 Impact Factor

Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.

PLoS One 2015 18;10(3):e0118919. Epub 2015 Mar 18.

Médecins sans Frontières (MSF, Doctors without Borders), Khayelitsha, Cape Town, South Africa; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0118919PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364980PMC
February 2016
30 Reads
3.234 Impact Factor

HIV and Ebola virus: two jumped species but not two of a kind.

AIDS 2015 Aug;29(13):1593-6

aHIV Unit, Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland bMédecins Sans Frontières cCentre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000776DOI Listing
August 2015
23 Reads
5.554 Impact Factor

Provision of antiretroviral therapy in South Africa: the nuts and bolts.

Antivir Ther 2014 13;19 Suppl 3:105-16. Epub 2014 Oct 13.

The Desmond Tutu HIV Centre, IDM and Medicine, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2905DOI Listing
June 2015
30 Reads
3.020 Impact Factor

Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.

J Acquir Immune Defic Syndr 2014 Oct;67(2):e55-66

*Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa; †Médecins Sans Frontières, Paris, France; ‡Médecins Sans Frontières, Amsterdam, Netherlands; §Médecins Sans Frontières, Geneva, Switzerland; ‖Médecins Sans Frontières, Cape Town, South Africa; ¶Epicentre, Paris, France; #Epicentre-Médecins Sans Frontières, Paris, France; and **University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000268DOI Listing
October 2014
18 Reads
4.556 Impact Factor

Community-supported models of care for people on HIV treatment in sub-Saharan Africa.

Trop Med Int Health 2014 Aug 28;19(8):968-77. Epub 2014 May 28.

Médecins Sans Frontières, Operational Centre Brussels, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tmi.12332DOI Listing
August 2014
30 Reads
2.329 Impact Factor

Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.

PLoS One 2013 5;8(6):e64392. Epub 2013 Jun 5.

Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://boris.unibe.ch/39054/1/fetchObject.pdf
Web Search
http://dx.plos.org/10.1371/journal.pone.0064392
Publisher Site
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0064392PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673971PMC
January 2014
38 Reads
3.234 Impact Factor

Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic.

Clin Infect Dis 2012 Dec 5;55(12):1698-706. Epub 2012 Sep 5.

Centre for Infectious Disease Research and Epidemiology, School of Public Health and Family Medicine, University of Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cis775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501332PMC
December 2012
5 Reads
8.886 Impact Factor

Public health. Getting HIV treatment to the most people.

Science 2012 Jul 12;337(6092):298-300. Epub 2012 Jul 12.

Médecins Sans Frontières Access Campaign, New York, NY 10001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1225702DOI Listing
July 2012
19 Reads
31.477 Impact Factor

Household screening and multidrug-resistant tuberculosis.

Lancet 2011 Jan 8;377(9760):103-4. Epub 2010 Dec 8.

Burnet Institute for Medical Research and Public Health, Centre for Population Health, Melbourne 3000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)61390-6DOI Listing
January 2011
6 Reads
45.217 Impact Factor

Extensively drug-resistant tuberculosis in South Africa.

Lancet 2010 Aug;376(9742):681; author reply 681-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)61327-XDOI Listing
August 2010
28 Reads
45.217 Impact Factor

AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.

J Int AIDS Soc 2010 Jul 8;13:23. Epub 2010 Jul 8.

Médecins Sans Frontières, Braamfontein, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1758-2652-13-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914751PMC
July 2010
4 Reads
5.090 Impact Factor

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

JAMA 2008 Aug;300(5):530-9

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.300.5.530DOI Listing
August 2008
6 Reads
35.289 Impact Factor

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

J Antimicrob Chemother 2008 Feb 19;61(2):389-93. Epub 2007 Dec 19.

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkm484DOI Listing
February 2008
5 Reads
5.313 Impact Factor

Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

Antivir Ther 2007 ;12(5):753-60

Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
October 2007
2 Reads
3.020 Impact Factor

Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.

Clin Infect Dis 2007 Jun 10;44(12):1639-46. Epub 2007 May 10.

Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
https://academic.oup.com/cid/article-lookup/doi/10.1086/5182
Publisher Site
http://dx.doi.org/10.1086/518234DOI Listing
June 2007
13 Reads
8.886 Impact Factor

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection.

Am J Respir Crit Care Med 2007 Mar 7;175(5):514-20. Epub 2006 Dec 7.

Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200610-1439OCDOI Listing
March 2007
6 Reads
12.996 Impact Factor

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa.

AIDS 2004 Jun;18 Suppl 3:S27-31

Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200406003-00006DOI Listing
June 2004
9 Reads
5.554 Impact Factor

Top co-authors

Gilles Van Cutsem
Gilles Van Cutsem

Médecins Sans Frontières

39
Gilles Van Cutsem
Gilles Van Cutsem

Médecins Sans Frontières

27
Andrew Boulle
Andrew Boulle

School of Public Health and Family Medicine

22
Eric Goemaere
Eric Goemaere

University of Cape Town

17
Amir Shroufi
Amir Shroufi

University of Cambridge

12
Robin Wood
Robin Wood

Institute of Infectious Disease and Molecular Medicine

11
Nathan Ford
Nathan Ford

Department of HIV/AIDS

10
Matthias Egger
Matthias Egger

Institute of Social and Preventive Medicine

10
Gary Maartens
Gary Maartens

University of Cape Town

9
David Coetzee
David Coetzee

University of Cape Town

9